New Consumer Health in Uzbekistan View larger

Consumer Health in Uzbekistan

M00011897

New product

In stock

$2,650.00

More info

Description

Consumer health is seeing more normalised sales figures in 2021 compared to 2020, when the event of the COVID-19 pandemic caused a number of fluctuations in both directions. It should be noted that Uzbekistan is a country with rather low purchasing power and consumers tended to opt for products they deemed to be more essential than those with a supplementary nature.

Euromonitor International's Consumer Health in Uzbekistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

Get a detailed picture of the Consumer Health market; Pinpoint growth sectors and identify factors driving change; Understand the competitive environment, the market's major players and leading brands; Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
Product Code: CHUZ

TABLE OF CONTENTS

List Of Contents And Tables

EXECUTIVE SUMMARY

Consumer health in 2021: The big picture 2021 key trends Competitive landscape Retailing developments What next for consumer health?

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021 Table 2 Life Expectancy at Birth 2016-2021

MARKET DATA

Table 3 Sales of Consumer Health by Category: Value 2016-2021 Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021 Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021 Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021 Table 7 Distribution of Consumer Health by Format: % Value 2016-2021 Table 8 Distribution of Consumer Health by Format and Category: % Value 2021 Table 9 Forecast Sales of Consumer Health by Category: Value 2021-2026 Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026

APPENDIX

OTC registration and classification Vitamins and dietary supplements registration and classification Self-medication/self-care and preventive medicine Switches

DISCLAIMER

DEFINITIONS

SOURCES

Summary 1 Research Sources

ANALGESICS IN UZBEKISTAN

KEY DATA FINDINGS

2021 DEVELOPMENTS

Analgesics shows slower growth in 2021, after the boom in 2020 caused by COVID-19 Basic options and low-cost brands continue to be in high demand Dolgit Cream maintains top place, as domestic brands as expected to grow stronger

PROSPECTS AND OPPORTUNITIES

Analgesics set to bounce back thanks to affordable prices and ongoing demand Children's analgesics continue to be supported by high birth rates Some polarisation between budget acetaminophen and higher-priced combination products expected

CATEGORY DATA

Table 11 Sales of Analgesics by Category: Value 2016-2021 Table 12 Sales of Analgesics by Category: % Value Growth 2016-2021 Table 13 NBO Company Shares of Analgesics: % Value 2017-2021 Table 14 LBN Brand Shares of Analgesics: % Value 2018-2021 Table 15 Forecast Sales of Analgesics by Category: Value 2021-2026 Table 16 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN UZBEKISTAN

KEY DATA FINDINGS

2021 DEVELOPMENTS

Sales of cough and cold remedies are stimulated by COVID-19 Allergies and hay fever make comebacks as pandemic restrictions lift GSK Consumer Healthcare maintains its lead, as domestic players struggle to compete with the global giants

PROSPECTS AND OPPORTUNITIES

Scope for growth in both developments and competition over the forecast period, thanks to category being unsaturated Demand for paediatric medicines will continue to bolster sales Sales in allergy remedies are set to be stable, with a boost expected as pandemic restrictions lift

CATEGORY DATA

Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021 Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021 Table 19 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021 Table 20 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021 Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026 Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026

DIGESTIVE REMEDIES IN UZBEKISTAN

KEY DATA FINDINGS

2021 DEVELOPMENTS

Digestive remedies partially rebounds in 2021, following lower sales in 2020 due to pandemic restrictions and low consumer spending power Ongoing growth supported by tradition of rich and fatty foods in the country, leading to obesity and a range of digestive issues Tight competition seen in digestive remedies, with global companies maintaining a stronghold

PROSPECTS AND OPPORTUNITIES

Moderate overall performance expected longer-term, after a stronger rebound in 2021-2022 Domestic players will only maintain small shares, despite support from the government Healthier diets and lifestyles in higher-income urban consumers will suppress sales

CATEGORY DATA

Table 23 Sales of Digestive Remedies by Category: Value 2016-2021 Table 24 Sales of Digestive Remedies by Category: % Value Growth 2016-2021 Table 25 NBO Company Shares of Digestive Remedies: % Value 2017-2021 Table 26 LBN Brand Shares of Digestive Remedies: % Value 2018-2021 Table 27 Forecast Sales of Digestive Remedies by Category: Value 2021-2026 Table 28 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026

DERMATOLOGICALS IN UZBEKISTAN

KEY DATA FINDINGS

2021 DEVELOPMENTS

As pandemic restrictions lift, sales begin to rise in dermatologicals again Specific trends seen in child-related categories, driven by increasing consumer spending power Global players hold advantages, but domestic Radiks maintains its strong and notable place

PROSPECTS AND OPPORTUNITIES

Future development of dermatologicals will depend on the Uzbekistan economy Essential categories which cannot be switched will support ongoing growth Higher standards of personal hygiene will place downwards pressure on certain sub-categories

CATEGORY DATA

Table 29 Sales of Dermatologicals by Category: Value 2016-2021 Table 30 Sales of Dermatologicals by Category: % Value Growth 2016-2021 Table 31 NBO Company Shares of Dermatologicals: % Value 2017-2021 Table 32 LBN Brand Shares of Dermatologicals: % Value 2018-2021 Table 33 Forecast Sales of Dermatologicals by Category: Value 2021-2026 Table 34 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026

WOUND CARE IN UZBEKISTAN

KEY DATA FINDINGS

2021 DEVELOPMENTS

Undynamic and saturated category leaves little room for developments Domestic player Sarbontex benefits from trend for low-cost products in wound care Price remains the most important factor for consumers' purchasing decisions in wound care

PROSPECTS AND OPPORTUNITIES

Very little change to the landscape of wound care expected over the forecast period Low popularity of sporting activities dampens demand for wound care Increasing presence of chemists/pharmacies ensures continued modest growth in wound care

CATEGORY DATA

Table 35 Sales of Wound Care by Category: Value 2016-2021 Table 36 Sales of Wound Care by Category: % Value Growth 2016-2021 Table 37 NBO Company Shares of Wound Care: % Value 2017-2021 Table 38 LBN Brand Shares of Wound Care: % Value 2018-2021 Table 39 Forecast Sales of Wound Care by Category: Value 2021-2026 Table 40 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026

VITAMINS IN UZBEKISTAN

KEY DATA FINDINGS

2021 DEVELOPMENTS

Vitamins records steep declines after the significant triple-digit spikes seen in sales in 2020 Single vitamins rise and fall more significantly than multivitamins, with sales expected to stabilise in 2021-2022 Competition is tight, with multinationals holding advantages over smaller domestic players

PROSPECTS AND OPPORTUNITIES

Slower growth figures expected after a rebound in 2021-2022, as spikes in popularity wane post-COVD-19 Multivitamins will continue to hold some appeal for higher-income consumers in a post-pandemic world Paediatric vitamins expected to remain popular, as parents prioritise their children's health over their own

CATEGORY DATA

Table 41 Sales of Vitamins by Category: Value 2016-2021 Table 42 Sales of Vitamins by Category: % Value Growth 2016-2021 Table 43 Sales of Multivitamins by Positioning: % Value 2016-2021 Table 44 NBO Company Shares of Vitamins: % Value 2017-2021 Table 45 LBN Brand Shares of Vitamins: % Value 2018-2021 Table 46 Forecast Sales of Vitamins by Category: Value 2021-2026 Table 47 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026

DIETARY SUPPLEMENTS IN UZBEKISTAN

KEY DATA FINDINGS

2021 DEVELOPMENTS

Dietary supplements recovers from the declines seen in 2020, as consumers reach out to health-strengthening supplements Paediatric Multi-tabs from GSK leads the way in child-focused developments Sanofi's leading Magne B6 offers the best of both worlds, with the super-popular vitamin B and magnesium

PROSPECTS AND OPPORTUNITIES

Dietary supplements expected to lose out to vitamins, due to higher prices and more vague health benefits Combinations with clear health benefit messages will be the most popular Domestic players on the rise with a range of innovative products

CATEGORY DATA

Table 48 Sales of Dietary Supplements by Category: Value 2016-2021 Table 49 Sales of Dietary Supplements by Category: % Value Growth 2016-2021 Table 50 Sales of Dietary Supplements by Positioning: % Value 2016-2021 Table 51 NBO Company Shares of Dietary Supplements: % Value 2017-2021 Table 52 LBN Brand Shares of Dietary Supplements: % Value 2018-2021 Table 53 Forecast Sales of Dietary Supplements by Category: Value 2021-2026 Table 54 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026

WEIGHT MANAGEMENT AND WELLBEING IN UZBEKISTAN

KEY DATA FINDINGS

2020 IMPACT

Weight management and wellbeing will remain a concentrated category Zamona Rano is the only local player active in weight management and wellbeing Weight loss supplements set to characterise the category

RECOVERY AND OPPORTUNITIES

Consumers will remain relatively unconcerned about controlling their weight Under-developed category due to scepticism and low demand Uzbek women are expected to be the target consumer base of players in this category

SPORTS NUTRITION IN UZBEKISTAN

KEY DATA FINDINGS

2021 DEVELOPMENTS

Niche category of sports nutrition sees stronger sales in 2021, as fitness centres and gymnasiums reopen Better education about protein products and sports nutrition will help boost sales Multinationals Weider and Optimum Nutrition maintain leads in the competitive landscape of sports nutrition

PROSPECTS AND OPPORTUNITIES

Health and wellness trends on the rise in urban areas Concentration on protein powder will remain, with little diversification and low levels of dynamism E-commerce set to be the most promising channel for sports nutrition

CATEGORY DATA

Table 55 Sales of Sports Nutrition by Category: Value 2016-2021 Table 56 Sales of Sports Nutrition by Category: % Value Growth 2016-2021 Table 57 NBO Company Shares of Sports Nutrition: % Value 2017-2021 Table 58 LBN Brand Shares of Sports Nutrition: % Value 2018-2021 Table 59 Forecast Sales of Sports Nutrition by Category: Value 2021-2026 Table 60 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026

HERBAL/TRADITIONAL PRODUCTS IN UZBEKISTAN

KEY DATA FINDINGS

2021 DEVELOPMENTS

Herbal/traditional products sees more normalised sales, after the fluctuations of 2020 due to the pandemic Herbal/traditional sleep aids and herbal/traditional cough, cold and allergy (hay fever) remedies do not see expected boost Affordability and availability remain the key drivers for sales, with Lek Pharmaceuticals maintaining its top place in fragmented category

PROSPECTS AND OPPORTUNITIES

Local players likely to grow, but unregulated category leads to a large quantity of counterfeit products No significant developments expected in undynamic category Low prices may help boost volume sales over the forecast period

CATEGORY DATA

Table 61 Sales of Herbal/Traditional Products: Value 2016-2021 Table 62 Sales of Herbal/Traditional Products: % Value Growth 2016-2021 Table 63 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021 Table 64 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021 Table 65 Forecast Sales of Herbal/Traditional Products: Value 2021-2026 Table 66 Forecast Sales of Herbal/Traditional Products: % Value Growth 2021-2026

PAEDIATRIC CONSUMER HEALTH IN UZBEKISTAN

KEY DATA FINDINGS

2021 DEVELOPMENTS

Fast-growing category thanks to parents being willing to purchase more expensive products to safeguard their children's health Demographics and return to school help sustain growth in the category Strong consumer loyalty towards recognised brands parents can trust

PROSPECTS AND OPPORTUNITIES

Stable growth supported by parents remaining loyal to quality brands Paediatric analgesics expected to be one of the most dynamic categories over the forecast period Improvements in healthcare offers continued potential for growth in paediatric consumer health

CATEGORY DATA

Table 67 Sales of Paediatric Consumer Health by Category: Value 2016-2021 Table 68 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021 Table 69 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021 Table 70 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026 Table 71 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026